Skip to content

Advertisement

Open Access

The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells

  • RS Muraoka-Cook1, 2,
  • C Husted1,
  • D Hunter1,
  • L Miraglia1 and
  • HS EarpIII1, 3, 4
Breast Cancer Research20057(Suppl 2):P3.02

https://doi.org/10.1186/bcr1124

Published: 17 June 2005

Keywords

ProlactinMammary Epithelial CellPhosphotyrosineLumen FormationHC11 Cell

Cell proliferation in the mammary epithelium is stimulated in part by EGF receptor activation, while differentiation requires ErbB4/HER4, prolactin and STAT5A [1]. Unlike other EGFR family members, HER4 undergoes ligand-dependent transmembrane domain cleavage, releasing a soluble 80 kDa tyrosine kinase (s80HER4) that localizes to the nucleus; the physiologic relevance of s80HER4 is unknown [2]. Using HC11 mouse mammary cells, we showed that EGF, HB-EGF and prolactin increased STAT5A phosphotyrosine and promoter transactivation, but only HB-EGF and prolactin induced differentiation markers and organization into polarized three-dimensional, lumen-containing structures in Matrigel. Heregulin did not stimulate lumen formation; rather, it increased and disorganized HC11 cell growth. Selective inhibition of ErbB1/ErbB2 activation unmasked heregulin-dependent differentiation and lumen formation. Kinase-dead HER4, or a HER4V675A mutant abolishing transmembrane cleavage, were expressed in HC11 cells. HC11 HER4kd or HER4V675A cells exhibited impaired HB-EGF and prolactin-dependent STAT5A translocation, promoter activation and lactogenic marker induction, indicating that both differentiation pathways need ErbB4 kinase activity and s80HER4 formation. HC11 cells constitutively expressing s80HER4 exhibited basal expression of differentiation markers, increased basal STAT5A activity and three-dimensional lumen formation. These results demonstrate that mammary cell differentiation can be stimulated by HER4 through a process requiring s80HER4 production.

Authors’ Affiliations

(1)
UNC Lineberger Comprehensive Cancer Center, UNC School of Medicine, Chapel Hill, USA
(2)
Department of Genetics, UNC School of Medicine, Chapel Hill, USA
(3)
Department of Medicine, UNC School of Medicine, Chapel Hill, USA
(4)
Department of Pharmacology, UNC School of Medicine, Chapel Hill, USA

References

  1. Long W, Wagner K-U, Lloyd KCK, Binart N, Shillingford JM, Hennighausen L, Jones FE: Impaired differentiation and lactational failure in ErbB4-deficient mammary glands identify ERBB4 as an obligate mediator of Stat5. Development. 2003, 130: 5257-5268. 10.1242/dev.00715.View ArticlePubMedGoogle Scholar
  2. Carpenter G: ErbB-4: mechanism of action and biology. Exp Cell Res. 2003, 284: 66-77. 10.1016/S0014-4827(02)00100-3.View ArticlePubMedGoogle Scholar

Copyright

© BioMed Central 2005

Advertisement